Chatfield Pharmaceuticals Limited

POWER SEARCH PRICING

SOLUTIONS

chatfield pharmaceuticals limited Company Information

Live

MatureMicroLow

Company Number

01003809

Website

http://genesis-pharma.com

Registered Address

2 leman street, london, E1W 9US

Industry

Manufacture of basic pharmaceutical products

Telephone

02073704664

Next Accounts Due

43 days late

Group Structure

View All

Directors

David Solomon24 Years

Charmian Solomon24 Years

Shareholders

david louis charles solomon 63%

jane celia frances soloman 37%

chatfield pharmaceuticals limited Estimated Valuation

£480.1k

Pomanda estimates the enterprise value of CHATFIELD PHARMACEUTICALS LIMITED at £480.1k based on a Turnover of £401.6k and 1.2x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Chatfield Pharmaceuticals Limited is a live company located in london, E1W 9US with a Companies House number of 01003809. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in March 1971, it's largest shareholder is david louis charles solomon with a 63% stake. Chatfield Pharmaceuticals Limited is a mature, micro sized company, Pomanda has estimated its turnover at £401.6k with low growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Chatfield Pharmaceuticals Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 9 areas for improvement. Company Health Check FAQs

Health Rating0.5out of 5

0 Strong

2 Regular

9 Weak

Size

annual sales of £401.6k, make it smaller than the average company (£30.7m)

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (3.6%)

EXPORT

Chatfield Pharmaceuticals Limited's latest turnover from December 2022 is estimated at £401.6 thousand and the company has net assets of £143.1 thousand. According to their latest financial statements, we estimate that Chatfield Pharmaceuticals Limited has 2 employees and maintains cash reserves of £27.7 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Sep 2009
Turnover	401,587	366,204	355,490	391,722	376,387	355,460	750,199	23,226	21,903,795	13,777,927	3,165,841	11,679,479	8,001,843	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	247,345	218,721	215,713	236,870	222,784	218,041	460,176	14,156	13,637,049	8,685,012	2,009,542	7,407,393	5,074,658	0
Gross Profit	154,242	147,483	139,776	154,852	153,603	137,419	290,023	9,070	8,266,746	5,092,915	1,156,299	4,272,086	2,927,185	0
Admin Expenses	213,205	221,284	102,884	-159,827	148,500	155,559	982,026	1,067,330	7,968,201	4,904,569	1,138,164	4,704,493	3,013,847	-2,596,192
Operating Profit	-58,963	-73,801	36,892	314,679	5,103	-18,140	-692,003	-1,058,260	298,545	188,346	18,135	-432,407	-86,662	2,596,192
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	1,086	80	153	1,266	940	965	452	1,691	1,585	378	231	867	1,190	484
Pre-Tax Profit	-57,877	-73,721	37,046	315,944	6,043	-17,175	-691,551	-1,056,569	300,130	188,725	18,366	-431,540	-85,472	2,596,676
Tax	0	0	-7,039	-60,029	-1,148	0	0	0	-63,027	-43,407	-4,408	0	0	-727,069
Profit After Tax	-57,877	-73,721	30,007	255,915	4,895	-17,175	-691,551	-1,056,569	237,103	145,318	13,958	-431,540	-85,472	1,869,607
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-57,877	-73,721	30,007	255,915	4,895	-17,175	-691,551	-1,056,569	237,103	145,318	13,958	-431,540	-85,472	1,869,607
Employee Costs	116,681	111,656	55,637	115,845	104,525	103,222	241,514	48,824	4,596,584	2,943,238	627,533	2,103,507	1,460,651	0
Number Of Employees	2	2	1	2	2	2	5	1	98	67	15	52	36	0
EBITDA*	-57,843	-72,965	38,000	315,111	5,724	-15,892	-687,057	-1,053,302	303,232	192,342	21,355	-424,856	-67,372	2,615,115

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Sep 2009
Tangible Assets	1,726	1,514	2,350	3,458	546	1,167	3,415	7,274	10,834	9,015	4,039	7,259	14,451	23,247
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	897,665	897,665	897,665	897,665
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	1,726	1,514	2,350	3,458	546	1,167	3,415	7,274	10,834	9,015	901,704	904,924	912,116	920,912
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	739,496	1,599,150
Trade Debtors	88,764	74,733	82,693	0	0	0	0	4,691	3,704,398	2,568,233	601,378	1,892,508	1,327,933	1,393,005
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	694,983	757,920	710,133	435,371	405,545	372,676	382,767	3,771,105	0	0	0	0	0	0
Cash	27,731	34,339	29,920	276,986	60,522	190,071	195,815	165,526	510,881	123,312	28,026	64,216	282,399	193,653
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	811,478	866,992	822,746	712,357	466,067	562,747	578,582	3,941,322	4,215,279	2,691,545	629,404	1,956,724	2,349,828	3,185,808
total assets	813,204	868,506	825,096	715,815	466,613	563,914	581,997	3,948,596	4,226,113	2,700,560	1,531,108	2,861,648	3,261,944	4,106,720
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	2,484	3,120	4,918	4,238	4,388	3,713	3,024	1,634	2,477,039	1,188,589	164,455	1,508,953	1,477,709	2,237,013
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	667,294	664,032	545,482	466,888	473,451	576,322	577,919	3,254,357	0	0	0	0	0	0
total current liabilities	669,778	667,152	550,400	471,126	477,839	580,035	580,943	3,255,991	2,477,039	1,188,589	164,455	1,508,953	1,477,709	2,237,013
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	328	379	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	328	379	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	670,106	667,531	550,400	471,126	477,839	580,035	580,943	3,255,991	2,477,039	1,188,589	164,455	1,508,953	1,477,709	2,237,013
net assets	143,098	200,975	274,696	244,689	-11,226	-16,121	1,054	692,605	1,749,074	1,511,971	1,366,653	1,352,695	1,784,235	1,869,707
total shareholders funds	143,098	200,975	274,696	244,689	-11,226	-16,121	1,054	692,605	1,749,074	1,511,971	1,366,653	1,352,695	1,784,235	1,869,707

	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Sep 2009
Operating Activities
Operating Profit	-58,963	-73,801	36,892	314,679	5,103	-18,140	-692,003	-1,058,260	298,545	188,346	18,135	-432,407	-86,662	2,596,192
Depreciation	1,120	836	1,108	432	621	2,248	4,946	4,958	4,687	3,996	3,220	7,551	19,290	18,923
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	-7,039	-60,029	-1,148	0	0	0	-63,027	-43,407	-4,408	0	0	-727,069
Stock	0	0	0	0	0	0	0	0	0	0	0	-739,496	-859,654	1,599,150
Debtors	-48,906	39,827	357,455	29,826	32,869	-10,091	-3,393,029	71,398	1,136,165	1,966,855	-1,291,130	564,575	-65,072	1,393,005
Creditors	-636	-1,798	680	-150	675	689	1,390	-2,475,405	1,288,450	1,024,134	-1,344,498	31,244	-759,304	2,237,013
Accruals and Deferred Income	3,262	118,550	78,594	-6,563	-102,871	-1,597	-2,676,438	3,254,357	0	0	0	0	0	0
Deferred Taxes & Provisions	-51	379	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-6,362	4,339	-247,220	218,543	-130,489	-6,709	30,924	-345,748	392,490	-793,786	-36,421	-218,691	98,050	1,132,904
Investing Activities
capital expenditure	-1,332	0	0	-3,344	0	0	-1,087	-1,398	-6,506	-8,972	0	-359	-10,494	-42,170
Change in Investments	0	0	0	0	0	0	0	0	0	-897,665	0	0	0	897,665
cash flow from investments	-1,332	0	0	-3,344	0	0	-1,087	-1,398	-6,506	888,693	0	-359	-10,494	-939,835
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	100	0	0	0	0	0	100
interest	1,086	80	153	1,266	940	965	452	1,691	1,585	378	231	867	1,190	484
cash flow from financing	1,086	80	153	1,266	940	965	452	1,791	1,585	378	231	867	1,190	584
cash and cash equivalents
cash	-6,608	4,419	-247,066	216,464	-129,549	-5,744	30,289	-345,355	387,569	95,286	-36,190	-218,183	88,746	193,653
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-6,608	4,419	-247,066	216,464	-129,549	-5,744	30,289	-345,355	387,569	95,286	-36,190	-218,183	88,746	193,653

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for chatfield pharmaceuticals limited. Get real-time insights into chatfield pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for chatfield pharmaceuticals limited by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in E1W area or any other competitors across 12 key performance metrics.

CHATFIELD PHARMACEUTICALS LIMITED group structure

Chatfield Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

CHATFIELD PHARMACEUTICALS LIMITED

01003809

CHATFIELD PHARMACEUTICALS LIMITED Shareholders

david louis charles solomon	63%
jane celia frances soloman	37%

Chatfield Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr David Solomon (Jul 2000) and Mrs. Charmian Solomon (Jul 2000).

officer	country	age	start	end	role
Mr David Solomon	United Kingdom	54 years	Jul 2000	-	Director
Mrs. Charmian Solomon		88 years	Jul 2000	-	Director

P&L

December 2022

turnover

401.6k

+10%

operating profit

-59k

gross margin

38.5%

-4.63%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

143.1k

-0.29%

total assets

813.2k

-0.06%

cash

27.7k

-0.19%

net assets

Total assets minus all liabilities

Similar Companies

moroccan natural resources limited

mento-neem international ltd

2.5

handiskin limited

2.5

trauma trays limited

1.5

compliance & validation solutions ltd

3.5

company number

01003809

Type

Private limited with Share Capital

industry

21100 - Manufacture of basic pharmaceutical products

incorporation date

March 1971

ultimate parent company

None

previous names

N/A

address

2 leman street, london, E1W 9US

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to chatfield pharmaceuticals limited.

chatfield pharmaceuticals limited Company Information

chatfield pharmaceuticals limited Estimated Valuation

chatfield pharmaceuticals limited Estimated Valuation

chatfield pharmaceuticals limited Estimated Valuation

Chatfield Pharmaceuticals Limited Overview

Chatfield Pharmaceuticals Limited Health Check

CHATFIELD PHARMACEUTICALS LIMITED financials

chatfield pharmaceuticals limited Credit Report and Business Information

Chatfield Pharmaceuticals Limited Competitor Analysis

chatfield pharmaceuticals limited Ownership

chatfield pharmaceuticals limited directors

chatfield pharmaceuticals limited company details

chatfield pharmaceuticals limited Charges & Mortgages

chatfield pharmaceuticals limited Companies House Filings - See Documents